Formulation, characterization, and evaluation of matrix-type transdermal patches of a model antihypertensive drug
Main Article Content
Abstract
methyl cellulose (6cps, 15cps, and K4M) for the development of transdermal drug delivery systems of nicorandil,
an antianginal drug. Prepared matrix-type patches were evaluated for their physicochemical characterization followed by
in vitro evaluation. Selected formulations were subjected for their ex vivo studies on porcine ear skin.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Rawat S, Vengurlekar S, Rakesh B, Jain S, Srikarti G. Transdermal delivery
by iontophoresis. Indian J Pharm Sci 2008;70:5-10.
Mohamed A, Yasmin S, Asgar A. Matrix type transdermal drug delivery
systems of metoprolol tartrate: In vitro characterization. Acta Pharm
;53:119-25.
Padmaja U, Prabha A, Prathibha P. Safety and efficacy of nicorandil in
chronic stable angina: A double blind comparative randomised trial with
isosorbide mononitrate. J Indian Acad Community Med 2003;4:205-9.
Raghuram Reddy K, Mutalik S,
Reddy S. Once-daily sustained-release
matrix tablets of nicorandil: Formulation and in vitro evaluation. AAPS
PharmSciTech 2003;4:4.
Shaila L, Pandey S, Udupa N. Design and evaluation of matrix type and
membrane controlled transdermal delivery systems of nicotine suitable
for use in smoking cessation. Indian J Pharm Sci 2006;68:179-84.
Krishnaiah YS, Satyanarayana V, Bhaskar P. Influence of limonene on
the bioavailability of nicardipine hydrochlorothiazide from membrane
modulated transdermal therapeutic systems in human volunteers. Int
J Pharm Krishnaiah 2002;247:91-102.
Bijaya G, Harivardhan RL, Raghvendra VK, Jasmina K. Comparison of
skin permeability of drugs in mice and human cadaver skin. Indian J
Exp Biol 2000;38:42-5.
Sadashivaiah R, Dinesh BM, Patil UA, Desai BG, Raghu KS. Design and in
vitro evaluation of haloperidol lactate transdermal patches containing
ethyl cellulose-povidone as film formers. Asian J Pharm 2008;2:43-9.
Katkam RR, Chakkapan S, Gandhi K, Thomas S, Puri CP,
Shrivastava R. Studies in transdermal drug delivery system for Estrodial.
Indian J Pharm Sci 1994;56:121-5.
Das MK, Bhattacharya A, Ghosal SK. Transdermal delivery of trazodone
hydrochloride from acrylic films prepared from aqueous latex. Indian
J Pharm Sci 2006;68:41-6.
Murthy TEGK, Mallikarjuna RP, Murali K. Design and development of
piroxicam transdermal films. Pharmacol Rev 2004;56:145-7.
Barry BW. Novel mechanism and devices to enable successful
transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14.
Wade Hull MS. Heat-enhanced transdermal drug delivery: A survey
paper. J Appl Res 2002;2:1-9.
Kr i shnaiah YS, Chandrasekhar DV, Rama B, Jayaram B,
Satyanarayana V, Al-Saidan SM. In vivo evaluation of limonene-based
transdermal therapeutic system of nicorandil in healthy human
volunteers. Skin Pharmacol Physiol 2004;18:263-72.
Chein YW. Transdermal drug delivery systems and delivery systems.
nd. Marcel Dekker, Inc; 1992. p. 301.
Libermann and Lachman. Pharmaceutical dosage forms. 2nd ed. Lea
and Febiger; 1990. p. 265.
Shukla AJ, Lee JC. Handbook of pharmaceutical excipients. 2nd ed. In:
Wade A, Wellers PJ, editors. American Pharmaceutical Association and
Royal Pharmaceutical society of Great Britain 1994. p. 362-6.
Shah HS, Tojo K, Chien YW. Transdermal controlled delivery of
verapamil: Characterization of in vitro skin permeation. Int J Pharm
;86:167-73.
Squillante E, Needham T, Zia H. Solubility and in vitro transdermal
permeation of nifedipine. Int J Pharm 1997;159:171-80.
Ghosh TK, Adir J, Xiang S, Onyilofur S. Transdermal delivery of
Metoprolol II: In vitro skin permeation and bioavailability in hairless
rats. J Pharm Sci 1995;84:158-60